Top Markets
Coin of the day
Bioptik Technology Incorporation Bioptik Technology Incorporation

Bioptik Technology Incorporation

4161
Pozycja w akcjach #26080
Bioptik Technology Incorporation operates as a global entity, focusing on the... Bioptik Technology Incorporation operates as a global entity, focusing on the creation and distribution of medical instruments and diagnostic chemicals. The company's product line encompasses the EasyMate series of blood glucose monitoring systems, as well as comprehensive diagnostic devices designed to measure blood glucose, cholesterol, and uric acid levels, complete with their essential test strips. Beyond its healthcare offerings, Bioptik also provides a range of skincare solutions, including those formulated with hyaluronic acid, alongside various dietary supplements. Uniquely, the company diversifies its business by supplying biodiesel products. Founded in 1999, Bioptik Technology Incorporation is headquartered in Zhunan, Taiwan.
Cena akcji
$0.72978769
Kapitalizacja rynkowa
$43.65M
Zmiana (1 dzień)
1.10%
Zmiana (1 rok)
-17.81%
Kraj
TW
Handel Bioptik Technology Incorporation (4161)

Kategoria

EPS dla Bioptik Technology Incorporation (4161)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy Bioptik Technology Incorporation, obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla Bioptik Technology Incorporation od 2026 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
Za mało danych dla podanych dat.
EPS dla podobnych firm lub konkurentów